"Passport Health is the leading provider of travel medicine in North America. For nearly 30 years, Passport Health has vaccinated countless global travelers against potentially deadly tropical diseases such as yellow fever and typhoid fever. With nearly 300 travel clinics across North America, Passport Health is proud to offer broad access to not just travel vaccines, but also valuable information to protect international travelers."

During the past decade, Passport Health conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Passport Health" are "Encephalitis" (1 trials) and "Typhoid Fever" (1 trials). Many other conditions were trialed in "Passport Health" in a lesser frequency.

Most popular intervention types in "Passport Health" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "IC51" (1 trials) and "Vivotif" (1 trials). Other intervention names were less common.

The vast majority of trials in "Passport Health" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Passport Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Passport Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Passport Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".